Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04701684 · ClinicalTrials.gov registry record · NA

WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

A NA study of Stroke, Acute, sponsored by Philips Clinical & Medical Affairs Global.

Recruiting
Registry status
NA
Development phase
594
Enrollment target
20
Study locations

NCT04701684 is a NA study of Stroke, Acute that is actively recruiting participants, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 594 participants, roughly in line with the 606-participant average among 25 other Stroke, Acute trials with a reported enrollment target. The trial reports 20 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04701684, a NA study of Stroke, Acute, is actively recruiting participants, sponsored by Philips Clinical & Medical Affairs Global.

RECRUITING
Registry status
NA
Development phase
594 participants
Enrollment target
20
Study locations

Study Summary

The WE-TRUST study is a multi-center randomized clinical trial to assess the impact of a Direct to Angio Suite (DTAS) workflow on stroke patient outcomes.

Conditions Studied

Stroke, Acute

Interventions

  • DEVICE Direct to Angio Suite (DTAS) Philips' CBCT triage
  • PROCEDURE Conventional CT/MR triage

Study Locations (20)

Other

  • La Sagrada Familia Clinic - José Hernández
  • UZ Brussels - Brussels
  • Hospital Geral de Fortaleza - Fortaleza
  • Hospital de Base - São José do Rio Preto
  • Hospital Estadual Central - Fundação Estadual de Inovação em Saúde - Inova Capixaba - Vitória
  • Hospices Civils de Lyon - Lyon
  • CHU Montpellier - Montpellier
  • Bicêtre Hospital - Paris
  • University Hospital Bonn (UKB Universitätsklinikum Bonn) - Bonn
  • Klinikum Kassel - Kassel
  • Universitätsklinikum Schleswig-Holstein Lübeck - Lübeck
  • Klinikum rechts der Isar der TU München - Munich
  • St. Antonius Ziekenhuis - Nieuwegein
  • Haaglanden Medical Center - The Hague
  • University Emergency Hospital Bucharest - Bucharest
  • Vall d'Hebron University Hospital - Barcelona

Florida

  • Baptist Medical Center - Jacksonville

Georgia

  • Grady Memorial Hospital/Emory University - Atlanta

New York

  • Montefiore Medical Center - The Bronx

Moncloa - Aravaca

  • Hospital Clinico San Carlos - Madrid

Trial Details

FieldValue
Enrollment Target 594 participants
Start Date 2021-06-23
Est. Completion 2027-04-01
Phase NA

Sponsor

Philips Clinical & Medical Affairs Global

45 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04701684

The ClinicalTrials.gov registry entry for NCT04701684 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 594 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 606-participant average among 25 other Stroke, Acute trials with a reported enrollment target. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke, Acute appearing as the primary indexed condition, and to 2 interventions - of which Direct to Angio Suite (DTAS) Philips' CBCT triage is the first listed.

NCT04701684 reports 20 study locations spanning 5 distinct geographic areas - top geographies include Other, Florida, Georgia.

Frequently Asked Questions

What is clinical trial NCT04701684 about?

NCT04701684 is a clinical study titled "WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)". The WE-TRUST study is a multi-center randomized clinical trial to assess the impact of a Direct to Angio Suite (DTAS) workflow on stroke patient outcomes.

What is the current status of trial NCT04701684?

This trial is currently recruiting. It is a NA study. The enrollment target is 594 participants. The study started on 2021-06-23. Estimated completion is 2027-04-01.

What conditions does trial NCT04701684 study?

This clinical trial studies the following conditions: Stroke, Acute.

What interventions are being tested in trial NCT04701684?

The interventions under investigation include: Direct to Angio Suite (DTAS) Philips' CBCT triage (DEVICE), Conventional CT/MR triage (PROCEDURE).

Who is sponsoring clinical trial NCT04701684?

This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04701684 being conducted?

This trial has 20 study locations across Florida, Georgia, New York, Moncloa - Aravaca. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke, Acute

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke, Acute

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.